FABP5 and lung carcinoma: In virtually all cancers studied, including hepatocellular carcinoma, gastric and colon cancers, glioma, skin cancer, lung cancer, renal cancer, prostate cancer (PC), and breast cancer, FABP5 expression is associated with increased tumor growth, migration, and/or invasiveness.